
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
The launch of CHIRALPAK® IJ gives access to an expanded range of solvents, which yields new separation not previously achievable on the coated CHIRALCEL® OJ.





